Drug Database
Back to search

France· FR:66063738

VEOZA 45 mg, comprimé pelliculé

A fezolinetant product containing fézolinétant, registered in France by ASTELLAS PHARMA EUROPE (PAYS-BAS). The same ATC class is registered in 14 of our 19 countries.

ATC G02CX06

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedVEOZA 45 mg, comprimé pelliculéATCG02CX06REGISTER NO.FR:66063738PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about fézolinétantAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Fezolinetant is registered in 14 of 19 countries.

Countries holding a registration under ATC G02CX06 (fezolinetant), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 9 of them publish a price we can compare per daily dose
Search fezolinetant products by name

Fezolinetant · ATC G02CX06

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of fezolinetant costs, country by country.

Normalised to the WHO defined daily dose (45 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Fezolinetant · price per daily dose (45 mg)

USD · FX 28 Sept 2026

  • ES Spain$3.02
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
FÉZOLINÉTANT
Manufacturer
ASTELLAS PHARMA EUROPE (PAYS-BAS)
Country
France (FR)
ATC code
G02CX06
ATC class
Fezolinetant
Defined daily dose
45 mg, O
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

  • cip13
    3400930283318
    30 plaquette(s) polyamide aluminium PVC-Aluminium de 1 comprimé (dose unitaire)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Fezolinetant in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All fezolinetant products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Veoza
  • Liechtenstein · Veoza
  • Norway · Veoza

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/a4b36438-5153-450a-9296-84bc8afeece0
GET /v1/drugs/a4b36438-5153-450a-9296-84bc8afeece0?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "66063738",
  "date_amm": "2023-12-07",
  "type_amm": "Procédure centralisée",
  "numero_ue": "EU/1/23/1771",
  "substance": "FÉZOLINÉTANT",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "comprimé pelliculé",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Oui"
}
API referenceMCP serverPlans

See everything about fezolinetant.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console